Skip to content

13F-HR filed by Anson Funds Management LP

Anson Funds Management LP filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-15, with 25 holding rows worth $134,149,000.

Accession
0001315863-18-000452
Filed
2018-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2018

A holdings report, 25 entries on the cover page, a total value of $134,149,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $134,149,000 with VALUE read as thousands by filing date, 13F file number 028-16678. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS301,000$79,208,000thousands by filing datecall
HD SUPPLY HLDGS INC40416M105COM392,125$6,610,000thousands by filing date
Microsoft Corp594918104COM59,787$5,457,000thousands by filing date
SHAW COMMUNICATIONS INC82028K200CL B CONV200,000$4,964,000thousands by filing date
WISDOMTREE TR97717W851JAPN HEDGE EQT86,000$4,817,000thousands by filing date
ALTA MESA RES INC 302133L117COM522,006$4,176,000thousands by filing date
RANDGOLD RES LTD752344309ADR50,000$4,162,000thousands by filing date
THE ONE GROUP HOSPITALITY IN88338K103COM1,213,821$3,338,000thousands by filing date
ALTA MESA RES INC02133L109CL A412,580$3,301,000thousands by filing date
SECOND SIGHT MED PRODS INC81362J118*W EXP 03/06/2021,337,580$2,568,000thousands by filing date
CAN-FITE BIOPHARMA LTD13471N102SPONSORED ADR1,357,586$1,955,000thousands by filing date
SPROTT PHYSICAL GOLD SILVER153501101COM120,000$1,586,000thousands by filing date
ACTINIUM PHARMACEUTICALS INC00507W107COM4,113,892$1,502,000thousands by filing date
GENIUS BRANDS INTERNATIONAL INC37229T301COMMON STOCK529,960$1,400,000thousands by filing date
SHOPIFY INC82509L107CL A SUB VTG SHS7,500$1,333,000thousands by filing date
SEANERGY MARITIME HLDGS CORPY73760145*W EXP 11/10/2021,432,500$1,250,000thousands by filing date
INTELLIPHARMACEUTICS INTERNA458173101CMN2,128,720$1,210,000thousands by filing date
SMITH MICRO SOFTWARE INC832154207COMMON714,286$1,063,000thousands by filing date
LONGFIN CORP CLASS A54304F106COMMON STOCK60,000$1,036,000thousands by filing dateput
IMAX CORP45245E109COM50,000$960,000thousands by filing date
ROKU INC COM CL A77543R102Stock30,000$933,000thousands by filing date
RXI PHARMACEUTICALS CORP NEW74979C121*W EXP 12/16/202222,173$715,000thousands by filing date
INTEC PHARMA LTD JERUSALEMM53644106SHS50,000$316,000thousands by filing date
INSPIREMD INC45779A135*W EXP 03/14/202250,000$260,000thousands by filing date
IMMUNOCELLULAR THERAPEUTICS452536121*W EXP 08/12/202117,188$29,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001315863-18-000452this filing2018-05-15acceptance time not in the bulk data set